Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORAD study of multi-month refill of anti-tuberculosis drugs in rural eastern Uganda
PACTR202403586718783Phase 3Not yet recruiting
- Sponsor
- University of California, Berkeley
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 3, open-label trial in Tuberculosis (TB) and pulmonary tuberculosis (TB) (2 arms), sponsored by University of California, Berkeley. Primary endpoint: Treatment success. Planned start Jun 2024; status: not yet recruiting.
02
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202403586718783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403586718783.